TY - JOUR
T1 - An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle
AU - H.gutmann, David
AU - B.andersen, Lone
AU - L.cole, Jeffery
AU - Swaroop, Manju
AU - S.collins, Francis
N1 - Funding Information:
We are grateful to Drs Jeff Chamberlain and Lawrence Elmer for providing many of the RNA samples used in this study. We also thank the members of the University of Michigan NFl group for their support, advice and encouragement during the course of this project. We appreciate Dr Tyler Jacks sharing his unpublished observations on the murine NFl knockout. This work was supported in part by NTH grant NS23410 (to FSC). DHG is the recipient of a Clinical Investigator Development Award from The National Institute of Neurological Diseases and Stroke (NS01590). FSC is an investigator in the Howard Hughes Medical Institute.
PY - 1993/7
Y1 - 1993/7
N2 - The gene for neurofibromatosis type 1 (NF1) was identified by positional cloning and found to contain two alternatively spliced exons. The first described alternatively spliced exon (exon 23a) is located within the GAP-related domain of the gene and inserts an additional 63 nucleotides into the NF1 mRNA. The second alternatively spliced exon (exon 48a) is located near the extreme carboxy terminus of the gene and inserts an additional 54 nucleotides into the mRNA. This second isoform, termed 3'ALT, was originally detected while screening a fetal brain cDNA library. Examination of its expression by reverse-transcribed RNA PCR demonstrates high level of expression in cardiac muscle, skeletal muscle and smooth muscle. Trace levels of expression are detected in brain and nerve. The 3'ALT isoform is expressed in fetal cardiac muscle, adult left ventricle and cardiac Purkinje cells. Further confirmation of the existence of this isoform was obtained by blotting the PCR products with a radiolabeled oligonucleotide entirely derived from sequences contained within exon 48a and by direct sequencing of the PCR products. Additionally, this isoform is expressed in muscle tissues from other vertebrate species. The expression of this isoform in muscle suggests that the NF1 gene may play additional tissue-specific roles in muscle development and signal transduction.
AB - The gene for neurofibromatosis type 1 (NF1) was identified by positional cloning and found to contain two alternatively spliced exons. The first described alternatively spliced exon (exon 23a) is located within the GAP-related domain of the gene and inserts an additional 63 nucleotides into the NF1 mRNA. The second alternatively spliced exon (exon 48a) is located near the extreme carboxy terminus of the gene and inserts an additional 54 nucleotides into the mRNA. This second isoform, termed 3'ALT, was originally detected while screening a fetal brain cDNA library. Examination of its expression by reverse-transcribed RNA PCR demonstrates high level of expression in cardiac muscle, skeletal muscle and smooth muscle. Trace levels of expression are detected in brain and nerve. The 3'ALT isoform is expressed in fetal cardiac muscle, adult left ventricle and cardiac Purkinje cells. Further confirmation of the existence of this isoform was obtained by blotting the PCR products with a radiolabeled oligonucleotide entirely derived from sequences contained within exon 48a and by direct sequencing of the PCR products. Additionally, this isoform is expressed in muscle tissues from other vertebrate species. The expression of this isoform in muscle suggests that the NF1 gene may play additional tissue-specific roles in muscle development and signal transduction.
UR - http://www.scopus.com/inward/record.url?scp=0027209850&partnerID=8YFLogxK
U2 - 10.1093/hmg/2.7.989
DO - 10.1093/hmg/2.7.989
M3 - Article
C2 - 8364582
AN - SCOPUS:0027209850
SN - 0964-6906
VL - 2
SP - 989
EP - 992
JO - Human molecular genetics
JF - Human molecular genetics
IS - 7
ER -